Dr Matthew Hurles
Matt moved to the Wellcome Trust Sanger Institute in 2003 to establish a group combining his interests in medical and population genetics.
Matt graduated with a degree in Biochemistry from Oxford University in 1996, and received his PhD from the University of Leicester in 1999 for work on the population genetics of human Y chromosomal polymorphisms. He then worked as a postdoctoral research fellow in population genetics at the University of Cambridge, focusing on the prehistory of Pacific populations and patterns of molecular evolution in duplicated sequences. During his postdoctoral research Matt established the molecular mechanism underlying a recurrent deletion of part of the Y chromosome, which causes male infertility.
Since 2003, Matt has led a major initiative to characterise structural variation in the human genome, and integrate this knowledge into disease and population genetic studies. This research combines large-scale data generation together with novel statistical analyses, and resulted in the first published genome-wide map of copy number variation in 2006, and along with Manolis Dermitzakis in 2007, demonstrated the impact of this form of variation on gene expression. His group has also developed novel experimental methods to probe the mutational mechanisms underlying genetic variation, which, in 2008, allowed identification of clinical syndromes that are being under-diagnosed. More recently, Dr Hurles has lead the construction of a comprehensive map of common copy number variation, and its integration into studies of common disease susceptibility, published in Nature in 2010. Dr Hurles also co-led, with Dr Sadaf Farooqi, the identification of nested microdeletions, which cause severe early-onset obesity, published in Nature in 2010. Dr Hurles is leading efforts at the Wellcome Trust Sanger Institute to apply genome-wide resequencing methods to the study of rare diseases.
In 2009, Matt was awarded the Balfour Lecture by the Genetics Society.
Matt currently has a leadership role in several large consortia, including the 1000 genomes project, the Deciphering Developmental Disorders initiative and the UK10K project.
Selected Publications
-
A map of human genome variation from population-scale sequencing.
Nature 2010;467;7319;1061-73
PUBMED: 20981092; PMC: 3042601; DOI: 10.1038/nature09534
-
Characterising and predicting haploinsufficiency in the human genome.
PLoS genetics 2010;6;10;e1001154
PUBMED: 20976243; PMC: 2954820; DOI: 10.1371/journal.pgen.1001154
-
Mutation spectrum revealed by breakpoint sequencing of human germline CNVs.
Nature genetics 2010;42;5;385-91
PUBMED: 20364136; PMC: 3428939; DOI: 10.1038/ng.564
-
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls.
Nature 2010;464;7289;713-20
PUBMED: 20360734; PMC: 2892339; DOI: 10.1038/nature08979
-
Origins and functional impact of copy number variation in the human genome.
Nature 2010;464;7289;704-12
PUBMED: 19812545; PMC: 3330748; DOI: 10.1038/nature08516
-
Large, rare chromosomal deletions associated with severe early-onset obesity.
Nature 2010;463;7281;666-70
PUBMED: 19966786; PMC: 3108883; DOI: 10.1038/nature08689
-
A robust statistical method for case-control association testing with copy number variation.
Nature genetics 2008;40;10;1245-52
PUBMED: 18776912; PMC: 2784596; DOI: 10.1038/ng.206
-
Germline rates of de novo meiotic deletions and duplications causing several genomic disorders.
Nature genetics 2008;40;1;90-5
PUBMED: 18059269; PMC: 2669897; DOI: 10.1038/ng.2007.40
-
Relative impact of nucleotide and copy number variation on gene expression phenotypes.
Science (New York, N.Y.) 2007;315;5813;848-53
PUBMED: 17289997; PMC: 2665772; DOI: 10.1126/science.1136678
-
Global variation in copy number in the human genome.
Nature 2006;444;7118;444-54
PUBMED: 17122850; PMC: 2669898; DOI: 10.1038/nature05329


